| Lincoln Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 531633 |
NSE Symbol : LINCOLN |
P/E(TTM) : 12.53 |
|
ISIN Demat : INE405C01035 |
Div & Yield% : 0.33 |
EPS(TTM) : 43.85 |
|
Book Value(₹) : 357.35 |
Market Cap(₹Cr) : 1,100.53 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 166.32 | 163.36 | 154.07 | 168.18 | 146.55 | 161.21 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 166.32 | 163.36 | 154.07 | 168.18 | 146.55 | 161.21 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 15.15 | 7.23 | 15.27 | -6.88 | 8.97 | 9.98 |
| Total Income | 181.47 | 170.60 | 169.34 | 161.30 | 155.52 | 171.19 |
| Total Expenditure | 142.73 | 137.94 | 130.26 | 141.46 | 122.89 | 132.83 |
| PBIDT | 38.74 | 32.66 | 39.08 | 19.84 | 32.63 | 38.36 |
| Interest | 0.30 | 0.23 | 0.21 | 0.37 | 0.73 | 0.35 |
| PBDT | 38.44 | 32.43 | 38.87 | 19.47 | 31.91 | 38.01 |
| Depreciation | 3.72 | 3.62 | 3.48 | 3.23 | 3.22 | 3.22 |
| Tax | 6.01 | 8.95 | 4.12 | 6.65 | 8.05 | 5.12 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.11 | -0.12 | 3.59 | -1.98 | -0.13 | 3.33 |
| Reported Profit After Tax | 28.60 | 19.98 | 27.68 | 11.58 | 20.77 | 26.33 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 28.60 | 19.98 | 27.68 | 11.58 | 20.77 | 26.33 |
| EPS (Unit Curr.) | 14.28 | 9.98 | 13.82 | 5.78 | 10.37 | 13.15 |
| EPS (Adj) (Unit Curr.) | 14.28 | 9.98 | 13.82 | 5.78 | 10.37 | 13.15 |
| Calculated EPS (Unit Curr.) | 14.28 | 9.98 | 13.82 | 5.78 | 10.37 | 13.15 |
| Calculated EPS (Adj) (Unit Curr.) | 14.28 | 9.98 | 13.82 | 5.78 | 10.37 | 13.15 |
| Calculated EPS (Ann.) (Unit Curr.) | 57.12 | 39.91 | 55.27 | 23.12 | 41.48 | 52.58 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 57.12 | 39.91 | 55.27 | 23.12 | 41.48 | 52.58 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 20.03 | 20.03 | 20.03 | 20.03 | 20.03 | 20.03 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 23.29 | 19.99 | 25.37 | 11.80 | 22.27 | 23.80 |
| PBDTM(%) | 23.11 | 19.85 | 25.23 | 11.58 | 21.77 | 23.58 |
| PATM(%) | 17.20 | 12.23 | 17.97 | 6.89 | 14.17 | 16.33 |
